Introduction Oral pre‐exposure prophylaxis (PrEP) has been scaled up; however, data from
real‐world settings are limited. We studied oral PrEP preference, uptake, adherence and …

Background There is limited information on factors that influence oral pre-exposure
prophylaxis (PrEP) uptake and adherence among adolescent girls and young women …

Introduction Oral tenofovir disoproxil fumarate/emtricitabine pre‐exposure prophylaxis
(PrEP), introduced into South Africa (SA) in 2016, has increasingly become part of HIV …

Background Oral Pre-Exposure Prophylaxis (PrEP) is an effective HIV prevention strategy for
adherent users. Adolescent girls and young women (AGYW) in sub-Saharan Africa may …

Despite demonstrated efficacy for HIV prevention, substantial challenges remain for the
successful rollout of oral pre-exposure prophylaxis (PrEP), especially among adolescent …

Daily oral pre-exposure prophylaxis (PrEP) is highly efficacious for HIV prevention.
Adolescent girls and young women (AGYW) have been prioritised for PrEP delivery in South …

Abstract Background In Kenya, South Africa, and Zimbabwe, oral pre-exposure prophylaxis
(PrEP) is recommended for adolescent girls and young women (AGYW) at high risk of HIV …

Adolescents and young women, particularly in South Africa, are at increased risk of HIV
acquisition. To date, we have had limited primary prevention options to offer. Oral pre …

Daily oral pre-exposure prophylaxis (PrEP) can safely and effectively prevent HIV
acquisition in HIV-negative individuals. However, uptake of PrEP has been suboptimal in …

Objective: To present detailed analyses of long-term pre-exposure prophylaxis (PrEP) use
and associated behaviors and perceptions among young Kenyan women. Design …